PEPTIDE VACCINE

The present invention provides one or more immunogenic peptides derived from a PRMT5-E2F1 axis regulated long non-coding RNA gene or a derivative thereof; a pharmaceutical composition comprising one or more of said peptides; a vaccine comprising one or more of said peptides and their use in therapy,...

Full description

Saved in:
Bibliographic Details
Main Authors BARCZAK, WOJCIECH, CARR, SIMON MARK, LA THANGUE, NICHOLAS
Format Patent
LanguageEnglish
French
Published 01.06.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides one or more immunogenic peptides derived from a PRMT5-E2F1 axis regulated long non-coding RNA gene or a derivative thereof; a pharmaceutical composition comprising one or more of said peptides; a vaccine comprising one or more of said peptides and their use in therapy, including a method for eliciting an immune response in a mammalian subject by administration of an agent capable of presenting the peptides to the host. The invention also relates to the use of a PRMT5 inhibitor for use in treating cancer by stimulating host immunity. La présente invention concerne un ou plusieurs peptides immunogènes dérivés d'un gène d'ARN long non codant régulé par l'axe PRMT5-E2F1 ou d'un dérivé de celui-ci ; une composition pharmaceutique comprenant un ou plusieurs desdits peptides ; un vaccin comprenant un ou plusieurs desdits peptides et leur utilisation en thérapie, y compris dans une méthode pour déclencher une réponse immunitaire chez un sujet mammifère par administration d'un agent capable de présenter les peptides à l'hôte. L'invention concerne également l'utilisation d'un inhibiteur de PRMT5 pour le traitement du cancer par stimulation de l'immunité de l'hôte.
AbstractList The present invention provides one or more immunogenic peptides derived from a PRMT5-E2F1 axis regulated long non-coding RNA gene or a derivative thereof; a pharmaceutical composition comprising one or more of said peptides; a vaccine comprising one or more of said peptides and their use in therapy, including a method for eliciting an immune response in a mammalian subject by administration of an agent capable of presenting the peptides to the host. The invention also relates to the use of a PRMT5 inhibitor for use in treating cancer by stimulating host immunity. La présente invention concerne un ou plusieurs peptides immunogènes dérivés d'un gène d'ARN long non codant régulé par l'axe PRMT5-E2F1 ou d'un dérivé de celui-ci ; une composition pharmaceutique comprenant un ou plusieurs desdits peptides ; un vaccin comprenant un ou plusieurs desdits peptides et leur utilisation en thérapie, y compris dans une méthode pour déclencher une réponse immunitaire chez un sujet mammifère par administration d'un agent capable de présenter les peptides à l'hôte. L'invention concerne également l'utilisation d'un inhibiteur de PRMT5 pour le traitement du cancer par stimulation de l'immunité de l'hôte.
Author LA THANGUE, NICHOLAS
BARCZAK, WOJCIECH
CARR, SIMON MARK
Author_xml – fullname: BARCZAK, WOJCIECH
– fullname: CARR, SIMON MARK
– fullname: LA THANGUE, NICHOLAS
BookMark eNrjYmDJy89L5WTgD3ANCPF0cVUIc3R29vRz5WFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8c6OxkbGlgYmxo6GxkQoAQBa0x5O
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate VACCIN PEPTIDIQUE
ExternalDocumentID CA3239043A1
GroupedDBID EVB
ID FETCH-epo_espacenet_CA3239043A13
IEDL.DBID EVB
IngestDate Fri Oct 18 06:01:34 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA3239043A13
Notes Application Number: CA20223239043
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230601&DB=EPODOC&CC=CA&NR=3239043A1
ParticipantIDs epo_espacenet_CA3239043A1
PublicationCentury 2000
PublicationDate 20230601
PublicationDateYYYYMMDD 2023-06-01
PublicationDate_xml – month: 06
  year: 2023
  text: 20230601
  day: 01
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies ARGONAUT THERAPEUTICS LIMITED
RelatedCompanies_xml – name: ARGONAUT THERAPEUTICS LIMITED
Score 3.477161
Snippet The present invention provides one or more immunogenic peptides derived from a PRMT5-E2F1 axis regulated long non-coding RNA gene or a derivative thereof; a...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title PEPTIDE VACCINE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230601&DB=EPODOC&locale=&CC=CA&NR=3239043A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTE2TDUwNk_TTTU3B3ZQjM0sdJPMDC10Tc2BzZFEU1Oz5ETQgL6vn5lHqIlXhGkEE0MmbC8M-JzQcvDhiMAclQzM7yXg8roAMYjlAl5bWayflAkUyrd3C7F1UYP2jkHtaWDf2MXJ1jXA38XfWc3Z2dbZUc0vyNbYCNi5NzF2BHaUWEGtaNAx-65hTqBNKQXINYqbIANbANCwvBIhBqbUPGEGTmfYxWvCDBy-0PluIBOa9YpFGPgDXANCPF1cFcIcnZ09_VxFGRTcXEOcPXSBJsfDfRHv7Ah3g7EYAwuwc58qwaBgCWzAJCWmATsVyYnAuhxYQSdZmCaamqeamySapRgkSjJI4jRGCo-cNAMXKDggi5pkGFhKikpTZYHVZ0mSHNjjAAzgb80
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfZ3dS8MwEMCPMcX5IjoV52cfpG_FzTRNfSjSpS2trl2ROvZW0i6DvczhKv77XmM3fdG3kMCRBC53v0vuAnA7IwPZJ2xuSMYQUIhlG4U1sA3K0B0RlFqlqAP6cWKFr-bTlE5bsNjkwqg6oZ-qOCJqVIn6XqnzevUTxPLU28r1XbHArrfHIHM8vaHj2p9GNvaGjp-OvTHXOXe4qycvDrlHuDeJi6C0w5AIFSlNhnVSyuq3RQkOYTdFYcvqCFpy2YUO33y81oW9uLnvxmajeutjOEj9NIs8X5u4nEeJfwJa4Gc8NFByvl1Fzt3tHMgptBHu5RloD-jAFGKOUFEKtOVooAubCsokM4U164se9P4Uc_7P2A10wiwe5aMoeb6A_Xprvh84XUK7ev-QV2hKq-JabcIXa7tytw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PEPTIDE+VACCINE&rft.inventor=BARCZAK%2C+WOJCIECH&rft.inventor=CARR%2C+SIMON+MARK&rft.inventor=LA+THANGUE%2C+NICHOLAS&rft.date=2023-06-01&rft.externalDBID=A1&rft.externalDocID=CA3239043A1